CN103409146A - Liquid crystal composition for active matrix driven liquid crystal display - Google Patents

Liquid crystal composition for active matrix driven liquid crystal display Download PDF

Info

Publication number
CN103409146A
CN103409146A CN2013101141750A CN201310114175A CN103409146A CN 103409146 A CN103409146 A CN 103409146A CN 2013101141750 A CN2013101141750 A CN 2013101141750A CN 201310114175 A CN201310114175 A CN 201310114175A CN 103409146 A CN103409146 A CN 103409146A
Authority
CN
China
Prior art keywords
formula
compound
nitrae
isosorbide
phenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101141750A
Other languages
Chinese (zh)
Other versions
CN103409146B (en
Inventor
华瑞茂
王奎
贠国良
贵丽红
杨增家
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shijiazhuang Chengzhi Yonghua Display Material Co Ltd
Original Assignee
Shijiazhuang Chengzhi Yonghua Display Material Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shijiazhuang Chengzhi Yonghua Display Material Co Ltd filed Critical Shijiazhuang Chengzhi Yonghua Display Material Co Ltd
Priority to CN201310114175.0A priority Critical patent/CN103409146B/en
Publication of CN103409146A publication Critical patent/CN103409146A/en
Application granted granted Critical
Publication of CN103409146B publication Critical patent/CN103409146B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Liquid Crystal Substances (AREA)

Abstract

The invention discloses a liquid crystal composition for active matrix driven liquid crystal display. The composition contains compounds shown in formulas I-III. According to the invention, a liquid crystal composition taking a difluoromethoxy-bridge simultaneously containing cyclopentyl in molecules thereof as a connecting group is used for improving the comprehensive performance of liquid crystal compositions so as to obtain different optimal combinations for meeting the needs of different display modes, therefore, the liquid crystal composition has an important practical value.

Description

Liquid-crystal composition for the driven with active matrix liquid-crystal display
Technical field
The present invention relates to a kind of liquid-crystal composition for the driven with active matrix liquid-crystal display.
Background technology
Utilize the different characteristic of liquid crystal material and mode of operation, liquid crystal display device can be designed to various operating mode.As twisted nematic mode, supertwist nematic-mode, supertwist birefringent mode, electrically controlled birefringence mode, in-plane-switching-mode etc.
In high information quantity shows, generally adopt active matrix (AM) mode to drive, more employing thin film transistor (TFT) drives at present.
In the AM-TFT element, the TFT switch device is by the matrix-style addressing, and in the non-conduction time, voltage changes, and the transmittance of pixel will change, and causes display quality to reduce.In order to overcome this phenomenon, require liquid crystal material that higher voltage retention is arranged, guarantee that the transmittance of pixel does not change.
Different operating mode and different type of drive require liquid-crystal composition suitable optical birefringence value Δ n to be arranged so that Δ nd reaches design load; Low threshold voltage is to realize low voltage drive; Lower viscosity is to meet the needs of quick response.
When modulation is applicable to the liquid-crystal composition of different LCD, need material to have suitable optical birefringence value, high dielectric anisotropy value, low fusing point and high clearing point, high voltage retention, low rotary viscosity, good thermostability and ultraviolet stability etc.
Do not have a kind of monomer liquid crystal compound can meet simultaneously the requirement of the various different working modes of liquid-crystal display.Suitably select monomer liquid crystal, and mix by a certain percentage, to meet the requirement of demonstration.
Summary of the invention
The purpose of this invention is to provide a kind of liquid-crystal composition for the driven with active matrix liquid-crystal display.
Liquid-crystal composition provided by the invention, comprise following formula I to compound shown in formula III;
Figure BDA00002996750900011
Formula I
Figure BDA00002996750900012
Formula II
Formula III
Described formula I to formula III, R 1And R 2All be selected from independently of one another at least a in the alkenyl of the alkoxyl group of alkyl, C1-C7 of hydrogen, fluorine, cyano group, trifluoromethyl, trifluoromethoxy, C1-C7 and C2-C5;
Wherein, the alkyl of described C1-C7 specifically is selected from least a in the alkyl of the alkyl of alkyl, C1-C2 of alkyl, the C1-C3 of alkyl, the C3-C4 of alkyl, the C2-C4 of alkyl, the C1-C4 of alkyl, the C4-C5 of alkyl, the C3-C5 of alkyl, the C2-C5 of alkyl, the C1-C5 of alkyl, the C5-C6 of alkyl, the C4-C6 of alkyl, the C3-C6 of alkyl, the C2-C6 of alkyl, the C1-C6 of alkyl, the C6-C7 of alkyl, the C5-C7 of alkyl, the C4-C7 of alkyl, the C3-C7 of C2-C7 and C2-C3;
The alkenyl of C2-C5 specifically is selected from least a in the alkenyl of the alkenyl of alkenyl, C4-C5 of alkenyl, the C3-C5 of alkenyl, the C3-C4 of C2-C4 and C2-C3;
The alkoxyl group of C1-C7 specifically is selected from the alkoxyl group of C2-C7, the alkoxyl group of C3-C7, the alkoxyl group of C4-C7, the alkoxyl group of C5-C7, the alkoxyl group of C6-C7, the alkoxyl group of C1-C6, the alkoxyl group of C2-C6, the alkoxyl group of C3-C6, the alkoxyl group of C4-C6, the alkoxyl group of C5-C6, the alkoxyl group of C1-C5, the alkoxyl group of C2-C5, the alkoxyl group of C3-C5, the alkoxyl group of C4-C5, the alkoxyl group of C1-C4, the alkoxyl group of C2-C4, the alkoxyl group of C3-C4, the alkoxyl group of C1-C3, at least a in the alkoxyl group of C1-C2 and the alkoxyl group of C2-C3,
Figure BDA00002996750900022
All be selected from Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-, 3, the fluoro-Isosorbide-5-Nitrae-phenylene of 5-bis-, cyclopentyl, 2, at least a in 5-oxa-cyclohexylidene and singly-bound;
L 1And L 2All be selected from least a in hydrogen and fluorine;
Z 1Be selected from-COO-,-CH 2CH 2-,-CH 2O-,-CF 2O-,-at least a in C ≡ C-and singly-bound;
N 1Be 0 or 1 or 2 or 3.
Above-mentioned liquid-crystal composition also can only be comprised of said components.
Shown in described formula I, the mass parts of compound is 6~65 parts, and the mass parts of compound shown in formula II is 5~55 parts, and the mass parts of compound shown in formula III is 1~60 part.
Concrete, the mass parts of compound shown in formula I is 20,22,38,49,48.5,49,53,58,20-58,20-53,20-48.5,20-38,20-22,22-58,22-53,22-48.5,22-38,38-58,38-53,38-48.5,48.5-58,48.5-53,48-58,49-58 or 53-58 part;
The mass parts of compound shown in formula II is specially 7,16,18,21,21.5,27,30,44,7-44,7-30,7-27,7-21,7-16,16-44,16-30,16-27,16-21,21-44,21-30,21-27,18-44,21.5-44,27-44,27-30 or 30-44 part;
The mass parts of compound shown in formula III is specially 13,18,21,25,27,29.5,34,46,50,13-50,13-46,13-27,13-21,13-18,18-50,18-46,18-27,18-21,21-50,21-46,21-27,27-50,27-46,13-34,25-50,25-46,13-25,29.5-50 or 46-50 part;
Described liquid-crystal composition also comprises shown in formula IV and formula V at least a in compound;
Figure BDA00002996750900031
Formula IV
Figure BDA00002996750900032
Formula V
In described formula IV and formula V, R 3And R 4All be selected from least a in the alkenyl of the alkoxyl group of alkyl, C1-C7 of hydrogen, fluorine, cyano group, trifluoromethyl, trifluoromethoxy, C1-C7 and C2-C5;
Wherein, the alkyl of described C1-C7 specifically is selected from least a in the alkyl of the alkyl of alkyl, C1-C2 of alkyl, the C1-C3 of alkyl, the C3-C4 of alkyl, the C2-C4 of alkyl, the C1-C4 of alkyl, the C4-C5 of alkyl, the C3-C5 of alkyl, the C2-C5 of alkyl, the C1-C5 of alkyl, the C5-C6 of alkyl, the C4-C6 of alkyl, the C3-C6 of alkyl, the C2-C6 of alkyl, the C1-C6 of alkyl, the C6-C7 of alkyl, the C5-C7 of alkyl, the C4-C7 of alkyl, the C3-C7 of C2-C7 and C2-C3;
The alkoxyl group of C1-C7 specifically is selected from the alkoxyl group of C2-C7, the alkoxyl group of C3-C7, the alkoxyl group of C4-C7, the alkoxyl group of C5-C7, the alkoxyl group of C6-C7, the alkoxyl group of C1-C6, the alkoxyl group of C2-C6, the alkoxyl group of C3-C6, the alkoxyl group of C4-C6, the alkoxyl group of C5-C6, the alkoxyl group of C1-C5, the alkoxyl group of C2-C5, the alkoxyl group of C3-C5, the alkoxyl group of C4-C5, the alkoxyl group of C1-C4, the alkoxyl group of C2-C4, the alkoxyl group of C3-C4, the alkoxyl group of C1-C3, at least a in the alkoxyl group of C1-C2 and the alkoxyl group of C2-C3,
The alkenyl of C2-C5 specifically is selected from least a in the alkenyl of the alkenyl of alkenyl, C4-C5 of alkenyl, the C3-C5 of alkenyl, the C3-C4 of C2-C4 and C2-C3;
Y is selected from least a in the thiazolinyl of the alkyl of cyano group, fluorine, trifluoromethyl, trifluoromethoxy, C1-C5 and C2-C5;
Wherein, the alkyl of described C1-C5 specifically is selected from least a in the alkyl of the alkyl of alkyl, C1-C2 of alkyl, the C1-C3 of alkyl, the C3-C4 of alkyl, the C2-C4 of alkyl, the C1-C4 of alkyl, the C4-C5 of alkyl, the C3-C5 of C2-C5 and C2-C3;
The thiazolinyl of C2-C5 specifically is selected from least a in the thiazolinyl of the thiazolinyl of thiazolinyl, C4-C5 of thiazolinyl, the C3-C5 of thiazolinyl, the C3-C4 of C2-C4 and C2-C3;
Figure BDA00002996750900041
All be selected from Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-, 3, at least a in the fluoro-Isosorbide-5-Nitrae-phenylene of 5-bis-and singly-bound;
L 3And L 4All be selected from least a in H and F;
Z 2Be selected from-COO-,-CH 2CH 2-,-CH 2O-,-at least a in C ≡ C-and singly-bound;
N 2Be 0 or 1 or 2.
Described liquid-crystal composition also can be only by least a composition the in compound shown in compound and formula IV and formula V shown in described formula I-formula III.
Shown in described formula IV and formula V, the mass parts of compound is 0~40 part, and the mass parts of formula IV and formula V compound is 0 when different; Preferably, shown in formula IV and formula V, the mass parts of compound is 0~30 part, is specially 3,3.5,4,5,6,8,9,3-9,3-8,3-6,3-5,5-6,5-9,5-8,3-4,3-3.5,4-9,4-8,4-6,6-9,6-8 or 8-9 part;
Compound shown in described formula I is compound shown in formula Ia:
Figure BDA00002996750900042
Formula Ia
In described formula Ia, R 2Identical with definition in aforementioned formula I; R 2Specifically be selected from least a in the alkenyl of the alkyl of C1-C5 and C2-C5;
Shown in described formula Ia, compound is specially
Figure BDA00002996750900044
In described formula II, R 1Be selected from least a in the alkyl of C1-C5;
R 2Be selected from least a in the alkenyl of the alkyl of fluorine, C1-C5 and C2-C5;
Figure BDA00002996750900045
All be selected from least a in Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-;
Shown in described formula IIa, compound is specially
Figure BDA00002996750900051
Compound shown in described formula III be compound shown in formula III a, formula III b, formula III c or
Figure BDA00002996750900053
Figure BDA00002996750900054
Formula III a
In described formula III a, R 1Identical with definition in aforementioned formula III; R 1Specifically be selected from least a in the alkyl of C3 and hydrogen;
Figure BDA00002996750900055
It is identical with definition in aforementioned formula III,
Figure BDA00002996750900056
Be specially Isosorbide-5-Nitrae-cyclohexylidene or Isosorbide-5-Nitrae-phenylene or the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-or singly-bound or cyclopentyl, and
Figure BDA00002996750900057
Identical or different;
Shown in described formula III a, compound is specially
Figure BDA00002996750900058
Figure BDA00002996750900059
Figure BDA000029967509000510
IIIb
In described formula III b, R 1Identical with definition in aforementioned formula III; R 1Specifically be selected from least a in the alkenyl of the alkyl of C1-C5 and C2-C4;
Figure BDA00002996750900061
It is identical with definition in aforementioned formula III,
Figure BDA00002996750900062
Specifically be selected from least a in Isosorbide-5-Nitrae-cyclohexylidene and Isosorbide-5-Nitrae-phenylene and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-;
Figure BDA00002996750900063
It is identical with definition in aforementioned formula III,
Figure BDA00002996750900064
Specifically all be selected from least a in Isosorbide-5-Nitrae-phenylene and Isosorbide-5-Nitrae-cyclohexylidene and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-;
L 1And L 2Identical with definition in aforementioned formula III, L 1And L 2Concrete all be selected from least a in hydrogen and fluorine;
R 2Identical with definition in aforementioned formula III, R 2Specifically be selected from least a in the alkenyl of the alkyl of fluorine, C1-C5 and C2-C5;
Shown in described formula III b, compound is specially
Figure BDA00002996750900065
Figure BDA00002996750900066
Figure BDA00002996750900067
Formula III c
In described formula III c, R 1Identical with definition in aforementioned formula III; R 1Specifically be selected from least a in the alkyl of C1-C5, more specifically be selected from least a in the alkyl of C2-C4;
Figure BDA00002996750900068
It is identical with definition in aforementioned formula III, Specifically be selected from least a in Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-and the fluoro-Isosorbide-5-Nitrae-phenylene of 3-;
Shown in described formula III c, compound is specially
Figure BDA00002996750900071
Figure BDA00002996750900072
Compound shown in described formula IV is compound shown in formula IVa:
Formula IVa
In described formula IVa, R 3Identical with definition in aforementioned formula IV; R 3Specifically be selected from least a in the alkyl of C1-C5;
Y is identical with definition in aforementioned formula IV; Y specifically be selected from fluorine and-OCF 3In at least a;
Shown in described formula IVa, compound is specially
Figure BDA00002996750900074
Figure BDA00002996750900075
Shown in described formula V, compound is specially
Figure BDA00002996750900077
Concrete, described liquid-crystal composition is to comprise or any one in composition I-IX that each compound of following mass parts forms;
In described composition I, the structural formula of each compound and mass parts are as follows:
Figure BDA00002996750900078
Figure BDA00002996750900081
In described composition I I, the structural formula of each compound and mass parts are as follows:
In described composition I II, the structural formula of each compound and mass parts are as follows:
Figure BDA00002996750900091
In described composition I V, the structural formula of each compound and mass parts are as follows:
Figure BDA00002996750900092
In described composition V, structural formula and the mass parts of each compound are as follows:
Figure BDA00002996750900101
In described composition VI, structural formula and the mass parts of each compound are as follows:
Figure BDA00002996750900102
In described composition VII, structural formula and the mass parts of each compound are as follows:
Figure BDA00002996750900112
Figure BDA00002996750900121
In described composition VIII, structural formula and the mass parts of each compound are as follows:
Figure BDA00002996750900122
In described composition I X, the structural formula of each compound and mass parts are as follows:
Figure BDA00002996750900123
The optical anisotropy Δ n of described liquid-crystal composition is 0.08-0.13; Clearing point CP is 69 ℃-110 ℃.
In addition, contain liquid crystal display device and the application of this liquid-crystal composition in the liquid crystal display device of preparation driven with active matrix of the driven with active matrix of the liquid-crystal composition that the invention described above provides, also belong to protection scope of the present invention.
Concrete, the liquid crystal display device of described driven with active matrix is indicating meter; The display format of described indicating meter is specially twisted nematic mode, supertwist nematic-mode, supertwist birefringent mode, electrically controlled birefringence mode, in-plane-switching-mode or fringe field switching mode.
The present invention has used the difluoro methoxy bridge that contains simultaneously cyclopentyl in the molecule liquid crystalline cpd as connected clique, in order to improve the over-all properties of liquid crystal compound.The time of response that the represented compound of formula I can reduce composition, the represented compound of formula II can reduce the viscosity of composition, the represented compound of formula III can improve Δ ε and the clearing point of composition and higher voltage retention is arranged, the represented compound of formula IV can increase the Δ ε of composition, the represented compound of formula IV is the Δ n of adjustable compositions also, and the represented compound of formula V can improve the clearing point of composition.This liquid-crystal composition is applicable to the liquid-crystal composition of the liquid crystal display device of active matrix thin film transistor (AM-TFT) driving, said composition by a certain percentage, is taken into account parameters, obtains different best of breeds, meet the needs of different display modes, have important practical value.
The accompanying drawing explanation
Fig. 1 is the viewing angle characteristic of embodiment 7 gained liquid-crystal compositions.
Fig. 2 is the response characteristic of embodiment 7 gained liquid-crystal compositions.
Fig. 3 is the photoelectric curve (V of embodiment 7 gained liquid-crystal compositions 10, V 90Test).
Embodiment
The present invention is further elaborated below in conjunction with specific embodiment, but the present invention is not limited to following examples.Described method is ordinary method if no special instructions.Described starting material all can obtain from open commercial sources if no special instructions.
In following embodiment, CP means clearing point, and Δ n means optical anisotropy (589nm, 20 ℃), and Δ ε means dielectric anisotropy, γ 1Mean rotary viscosity, V 10Mean the voltage when in electro-optical curve, transmitance is 10% relatively, V 90Mean the voltage when in electro-optical curve, transmitance is 90% relatively, concrete measuring method is specific as follows:
1, Δ n:589nm, 20 ℃, ZWA-J type Abbe refractometer;
2, Δ ε: 25 ℃, 1KHz, parallel box, HP-4284A photoelectricity test instrument;
3, the micro-thermal analyzer of CP:WRX-1S, setting temperature rise rate is 3 ℃/min.
4, γ 1: 25 ℃, 20.0 microns parallel boxes, TOYO SR-6254 viscosity tester.
V 10, V 90Measuring method as follows: liquid-crystal composition is inserted in the left-handed TN liquid crystal cell of 5.2 μ m, uses LCT-5016 photoelectricity test instrument, measure at 25 ℃ of temperature.
Table 1, table 2, table 3, table 4 provide the symbol of common structure fragment, and complex compound means with structural formula.
Table 1, ring structure subunit title abbreviation table
Figure BDA00002996750900141
Table 2, linking group title abbreviation table
Figure BDA00002996750900151
Table 3, end group title abbreviation table
Figure BDA00002996750900152
Wherein n and m are natural numbers.
Table 4, simple group example
F means fluorine CL means chlorine
CN means cyano group CF 3Mean trifluoromethyl
CF 3O means trifluoromethoxy ?
Complex compound means with structural formula:
Figure BDA00002996750900153
Figure BDA00002996750900154
Shown in structure symbolically in the following example:
Figure BDA00002996750900161
Embodiment 1
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900162
The physical parameter test result of this liquid-crystal composition is as follows:
CP=82℃;Δn=0.101;Δε=3.8;V 10=2.07V;V 90=3.12V;γ 1=67。
As can be seen from the above results, said composition has lower rotary viscosity γ 1, threshold value V 10Lower (seeing Fig. 3), the time of response fast (seeing Fig. 2), viewing angle characteristic as shown in Figure 1, is a over-all properties liquid-crystal composition preferably, is applicable to TFT and drives liquid-crystal display.
Embodiment 2
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
The physical parameter test result of this liquid-crystal composition is as follows:
Δn=0.118,CP=75.8℃,V10=2.08,V90=2.95,Δε=4.43,γ 1=46.2。
As from the foregoing, said composition contains the 5-membered ring compounds that F-1 means, V10 and V90 reduce, and clearing point slightly raises, and these parameters change the performance of the liquid-crystal display that is conducive to improve driven with active matrix.
Embodiment 3:
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900172
Figure BDA00002996750900181
The physical parameter test result of this liquid-crystal composition is as follows:
CP=83℃;Δn=0.102;Δε=3.9;V 10=2.04V;V 90=3.08V;γ 1=68。
As can be seen from the above results, said composition has lower rotary viscosity γ 1=68, threshold value V 10Lower, over-all properties is the mixed liquid crystal composition preferably, is applicable to the liquid-crystal display of driven with active matrix.
Embodiment 4
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900182
The physical parameter test result of this liquid-crystal composition is as follows:
CP=80.8℃;Δn=0.102;Δε=3.61;V 10=2.26V;V 90=3.40V。
As from the foregoing, the composition of said composition is simple, can be used for passive and liquid-crystal display driven with active matrix.
Embodiment 5
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900192
Figure BDA00002996750900201
The physical parameter test result of this liquid-crystal composition is as follows:
CP=90℃;Δn=0.100;Δε=7。
As from the foregoing, the said composition clearing point is higher, and Δ n drops between the expected range 0.08~0.12 of optical anisotropy (Δ n) value that TFT-LCD is complementary.
Embodiment 6
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900202
Figure BDA00002996750900211
The physical parameter test result of this liquid-crystal composition is as follows:
CP=92℃;Δn=0.100;Δε=7.2。
As from the foregoing, the said composition clearing point is higher, and Δ n drops between the expected range 0.08~0.12 of optical anisotropy (Δ n) value that TFT-LCD is complementary, and Δ ε is larger, is conducive to low voltage drive.
Embodiment 7
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900212
The physical parameter test result of this liquid-crystal composition is as follows:
Δn=0.114,CP=81.3℃,V10=2.84,V90=3.84,Δε=2.7,γ 1=48.8;
As from the foregoing, said composition can be for the driven with active matrix of liquid-crystal display.
Embodiment 8
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900222
The physical parameter test result of this liquid-crystal composition is as follows:
CP=74℃;Δn=0.115;Δε=3.2;V10=2.57;V90=3.63;
As from the foregoing, said composition Δ n drops between the expected range 0.08~0.12 of optical anisotropy (Δ n) value that TFT-LCD is complementary, and Δ ε is larger, is conducive to low voltage drive.
Embodiment 9
According to following mass percent, each compound is mixed, obtains liquid-crystal composition:
Figure BDA00002996750900231
The physical parameter test result of this liquid-crystal composition is as follows:
CP=76℃;Δn=0.108;Δε=5.7;V10=1.78;V90=2.66;
As from the foregoing, said composition Δ n drops between the expected range 0.08~0.12 of optical anisotropy (Δ n) value that TFT-LCD is complementary, and Δ ε is larger, is conducive to low voltage drive.

Claims (10)

1. a liquid-crystal composition, comprise formula I to compound shown in formula III;
Figure FDA00002996750800011
Formula I
Figure FDA00002996750800012
Formula II
Figure FDA00002996750800013
Formula III
Described formula I to formula III, R 1And R 2All be selected from least a in the alkenyl of the alkoxyl group of alkyl, C1-C7 of hydrogen, fluorine, cyano group, trifluoromethyl, trifluoromethoxy, C1-C7 and C2-C5;
Figure FDA00002996750800014
All be selected from Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-, 3, the fluoro-Isosorbide-5-Nitrae-phenylene of 5-bis-, cyclopentyl, 2, at least a in 5-oxa-cyclohexylidene and singly-bound;
L 1And L 2All be selected from least a in hydrogen and fluorine;
Z 1Be selected from-COO-,-CH 2CH 2-,-CH 2O-,-CF 2O-,-at least a in C ≡ C-and singly-bound;
N 1Be 0 or 1 or 2 or 3.
2. liquid-crystal composition according to claim 1 is characterized in that: described liquid-crystal composition is comprised of to compound shown in formula III described formula I.
3. liquid-crystal composition according to claim 1 and 2, it is characterized in that: shown in described formula I, the mass parts of compound is 6~65 parts, and the mass parts of compound shown in formula II is 5~55 parts, and the mass parts of compound shown in formula III is 1~60 part.
4. according to the arbitrary described liquid-crystal composition of claim 1-3, it is characterized in that: described liquid-crystal composition also comprises shown in formula IV and formula V at least a in compound;
Figure FDA00002996750800015
Formula IV
Figure FDA00002996750800021
Formula V
In described formula IV and formula V, R 3, R 4With Y, all be selected from least a in the alkenyl of the alkoxyl group of alkyl, C1-C7 of C1-C7 and C2-C5;
Figure FDA00002996750800022
All be selected from Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-, 3, at least a in the fluoro-Isosorbide-5-Nitrae-phenylene of 5-bis-and singly-bound;
L 3And L 4All be selected from least a in H and F;
Z 2Be selected from-COO-,-CH 2CH 2-,-CH 2O-,-at least a in C ≡ C-and singly-bound;
N 2Be 0 or 1 or 2.
5. according to the arbitrary described liquid-crystal composition of claim 1-4, it is characterized in that: shown in described formula IV and formula V, the mass parts of compound is 0~40 part, and the mass parts of formula IV and formula V compound is 0 when different, specifically is 0~30 part.
6. according to the arbitrary described liquid-crystal composition of claim 1-5, it is characterized in that: described liquid-crystal composition is by least a composition the in compound shown in compound and formula IV and formula V shown in described formula I-formula III.
7. according to the arbitrary described liquid-crystal composition of claim 1-6, it is characterized in that: shown in described formula I, be compound shown in formula Ia in compound:
Figure FDA00002996750800023
Formula Ia
In described formula Ia, R 1And R 2Identical with definition in claim 1 Chinese style I; R 2Specifically be selected from least a in the alkenyl of the alkyl of C1-C5 and C2-C5; Or,
Shown in described formula Ia, compound is specially
Figure FDA00002996750800025
In described formula II, R 1Be selected from least a in the alkyl of C1-C5;
R 2Be selected from least a in the alkenyl of the alkyl of fluorine, C1-C5 and C2-C5;
Figure FDA00002996750800031
All be selected from least a in Isosorbide-5-Nitrae-cyclohexylidene, Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-, the fluoro-Isosorbide-5-Nitrae-phenylene of 3-and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-; Or,
Shown in described formula IIa, compound is specially
Figure FDA00002996750800032
Figure FDA00002996750800033
Compound shown in described formula III be compound shown in formula III a, formula III b, formula III c or
Figure FDA00002996750800034
Figure FDA00002996750800035
Formula III a
In described formula III a, R 1Identical with definition in formula III in claim 1; R 1Specifically be selected from least a in the alkyl of C1-C5 and hydrogen;
It is identical with definition in formula III in claim 1,
Figure FDA00002996750800037
Be specially Isosorbide-5-Nitrae-cyclohexylidene or Isosorbide-5-Nitrae-phenylene or the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-or singly-bound or cyclopentyl, and
Figure FDA00002996750800038
Identical or different; Or,
Shown in described formula III a, compound is specially
Figure FDA00002996750800039
Figure FDA00002996750800041
Formula III b
In described formula III b, R 1Identical with definition in formula III in claim 1; R 1Specifically be selected from least a in the alkenyl of the alkyl of C1-C5 and C2-C5;
It is identical with definition in formula III in claim 1,
Figure FDA00002996750800044
Specifically be selected from least a in Isosorbide-5-Nitrae-cyclohexylidene and Isosorbide-5-Nitrae-phenylene and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-;
It is identical with definition in formula III in claim 1,
Figure FDA00002996750800046
Specifically all be selected from least a in Isosorbide-5-Nitrae-phenylene and Isosorbide-5-Nitrae-cyclohexylidene and the fluoro-Isosorbide-5-Nitrae-phenylene of 3,5-bis-;
L 1And L 2Identical with definition in formula III in claim 1, L 1And L 2Concrete all be selected from least a in hydrogen and fluorine;
R 2Identical with definition in formula III in claim 1, R 2Specifically be selected from least a in the alkenyl of the alkyl of fluorine, C1-C5 and C2-C5; Or,
Shown in described formula III b, compound is specially
Figure FDA00002996750800047
Figure FDA00002996750800048
Figure FDA00002996750800051
Formula III c
In described formula III c, R 1Identical with definition in formula III in claim 1; R 1Specifically be selected from least a in the alkyl of C1-C5, more specifically be selected from least a in the alkyl of C2-C4;
It is identical with definition in formula III in claim 1,
Figure FDA00002996750800053
Specifically be selected from least a in Isosorbide-5-Nitrae-phenylene, the fluoro-Isosorbide-5-Nitrae-phenylene of 2-and the fluoro-Isosorbide-5-Nitrae-phenylene of 3-; Or,
Shown in described formula III c, compound is specially
Figure FDA00002996750800054
Figure FDA00002996750800055
Compound shown in described formula IV is compound shown in formula IVa:
Figure FDA00002996750800056
Formula IVa
In described formula IVa, R 3Identical with definition in claim 4 Chinese style IV; R 3Specifically be selected from least a in the alkyl of C1-C5;
Y is identical with definition in claim 4 Chinese style IV; Y specifically be selected from fluorine and-OCF 3In at least a; Or,
Shown in described formula IVa, compound is specially
Figure FDA00002996750800057
Figure FDA00002996750800058
Shown in described formula V, compound is
Figure FDA00002996750800059
Figure FDA000029967508000510
8. according to the arbitrary described liquid-crystal composition of claim 1-7, it is characterized in that: the optical anisotropy of described liquid-crystal composition is 0.08-0.13; And/or,
Clearing point is 69 ℃-110 ℃.
9. according to the arbitrary described liquid-crystal composition of claim 1-8, it is characterized in that: described liquid-crystal composition is to comprise or any one in composition I-IX that each compound of following mass parts forms;
In described composition I, the structural formula of each compound and mass parts are as follows:
Figure FDA00002996750800061
In described composition I I, the structural formula of each compound and mass parts are as follows:
Figure FDA00002996750800062
Figure FDA00002996750800071
In described composition I II, the structural formula of each compound and mass parts are as follows:
Figure FDA00002996750800072
In described composition I V, the structural formula of each compound and mass parts are as follows:
Figure FDA00002996750800073
Figure FDA00002996750800081
In described composition V, structural formula and the mass parts of each compound are as follows:
In described composition VI, structural formula and the mass parts of each compound are as follows:
Figure FDA00002996750800092
In described composition VII, structural formula and the mass parts of each compound are as follows:
Figure FDA00002996750800093
Figure FDA00002996750800101
In described composition VIII, structural formula and the mass parts of each compound are as follows:
Figure FDA00002996750800102
In described composition I X, the structural formula of each compound and mass parts are as follows:
10. the liquid crystal display device that contains the driven with active matrix of the arbitrary described liquid-crystal composition of claim 1-9; Or,
The application of the arbitrary described liquid-crystal composition of claim 1-9 in the liquid crystal display device of preparation driven with active matrix; Or,
The liquid crystal display device of described driven with active matrix is specially indicating meter; Or,
The display format of described indicating meter is specially twisted nematic mode, supertwist nematic-mode, supertwist birefringent mode, electrically controlled birefringence mode, in-plane-switching-mode or fringe field switching mode.
CN201310114175.0A 2013-04-01 2013-04-01 For the liquid-crystal composition of driven with active matrix liquid-crystal display Active CN103409146B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310114175.0A CN103409146B (en) 2013-04-01 2013-04-01 For the liquid-crystal composition of driven with active matrix liquid-crystal display

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310114175.0A CN103409146B (en) 2013-04-01 2013-04-01 For the liquid-crystal composition of driven with active matrix liquid-crystal display

Publications (2)

Publication Number Publication Date
CN103409146A true CN103409146A (en) 2013-11-27
CN103409146B CN103409146B (en) 2015-10-28

Family

ID=49602189

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310114175.0A Active CN103409146B (en) 2013-04-01 2013-04-01 For the liquid-crystal composition of driven with active matrix liquid-crystal display

Country Status (1)

Country Link
CN (1) CN103409146B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103254905A (en) * 2013-04-25 2013-08-21 石家庄诚志永华显示材料有限公司 Liquid crystal display composition
CN103289708A (en) * 2013-06-09 2013-09-11 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropic liquid crystal composition
CN103351880A (en) * 2013-07-10 2013-10-16 石家庄诚志永华显示材料有限公司 Liquid crystal composition containing difluoromethoxy bridge polar monomer compound
CN103351871A (en) * 2013-07-09 2013-10-16 石家庄诚志永华显示材料有限公司 Liquid crystal medium suitable for TFT liquid crystal displays
CN104479689A (en) * 2014-12-29 2015-04-01 石家庄诚志永华显示材料有限公司 Liquid crystal composition
CN104560058A (en) * 2015-01-13 2015-04-29 石家庄诚志永华显示材料有限公司 Liquid crystal composition and application thereof in liquid crystal display
CN105441088A (en) * 2015-12-08 2016-03-30 石家庄诚志永华显示材料有限公司 Liquid crystal composition and liquid crystal display element or liquid crystal display containing liquid crystal composition
CN111117658A (en) * 2018-10-30 2020-05-08 江苏和成显示科技有限公司 Liquid crystal composition and display device thereof

Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080099726A1 (en) * 2006-10-31 2008-05-01 Chisso Corporation And Chisso Petrochemical Corporation Liquid crystal composition and liquid crystal display device
CN101544894A (en) * 2009-05-07 2009-09-30 石家庄永生华清液晶有限公司 Liquid crystal composition
CN102888228A (en) * 2012-10-13 2013-01-23 江苏和成显示科技股份有限公司 Liquid crystal composition and display comprising same
CN102898272A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Hexahydroindene-containing novel liquid crystal and composition and use thereof in liquid crystal displayers
CN102899051A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Liquid crystal medium and displayer having same
CN102898413A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Novel liquid crystal compound with dioxa saturated indene ring and composition thereof
CN102899054A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Liquid crystal composition with improved liquid crystal low-temperature smectic phase
CN102911673A (en) * 2012-10-13 2013-02-06 江苏和成显示科技股份有限公司 Liquid crystal composite and electro-optical display device comprising same
CN102924243A (en) * 2012-03-27 2013-02-13 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and applications thereof
CN102964226A (en) * 2012-12-14 2013-03-13 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclobutyl and difluoromethylenedioxy connecting radical as well as preparation method and application thereof
CN102994098A (en) * 2012-05-03 2013-03-27 石家庄诚志永华显示材料有限公司 TFT (Thin Film Transistor) liquid crystal composition and preparation method and application thereof
CN102994100A (en) * 2012-10-11 2013-03-27 江苏和成显示科技股份有限公司 Liquid crystal composition and liquid crystal display device containing liquid crystal composition
CN103058947A (en) * 2012-12-24 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing benzoxazole and difluoromethylenedioxy bridged linkage and preparation method and application thereof
CN103058836A (en) * 2012-01-18 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing indan and difluoro methylenedioxy bridge, as well as preparation method and application thereof
CN103058968A (en) * 2012-12-24 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing benzoxazole and difluoromethylenedioxy bridged linkage and preparation method and application thereof
CN103087037A (en) * 2012-12-20 2013-05-08 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing 1, 3-dioxolane and difluoro-methylenedioxy linking group and preparation method and application of liquid crystal compound
CN103131426A (en) * 2011-11-25 2013-06-05 达兴材料股份有限公司 Liquid crystal compound and liquid crystal medium
CN103146392A (en) * 2013-02-27 2013-06-12 北京八亿时空液晶科技股份有限公司 Liquid crystal composition for liquid crystal display
CN103205265A (en) * 2013-03-14 2013-07-17 江苏和成显示科技股份有限公司 Liquid crystal composition and liquid crystal display device
CN103205261A (en) * 2013-03-06 2013-07-17 石家庄诚志永华显示材料有限公司 Nematic liquid crystal medium composition
CN103319444A (en) * 2012-06-20 2013-09-25 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing 4-tetrahydropyran structure and preparation method and application thereof
CN103320144A (en) * 2012-06-20 2013-09-25 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing dihydrobenzofuran and preparation method and application thereof
CN103333146A (en) * 2012-06-20 2013-10-02 石家庄诚志永华显示材料有限公司 Liquid crystal compounds containing 2-alkyltetrahydropyrane structure, and preparation method and application thereof
CN103333139A (en) * 2012-06-20 2013-10-02 石家庄诚志永华显示材料有限公司 Liquid crystal compounds containing tetrahydrofuran structure
CN103467251A (en) * 2012-09-24 2013-12-25 石家庄诚志永华显示材料有限公司 Adamantane derivative and preparation method and application thereof
CN103467253A (en) * 2012-09-24 2013-12-25 石家庄诚志永华显示材料有限公司 Cycloheptane derivative as well as preparation method and application thereof
CN103602337A (en) * 2012-08-17 2014-02-26 石家庄诚志永华显示材料有限公司 Cyclohexane derivatives, preparation method thereof and applications thereof

Patent Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080099726A1 (en) * 2006-10-31 2008-05-01 Chisso Corporation And Chisso Petrochemical Corporation Liquid crystal composition and liquid crystal display device
CN101544894A (en) * 2009-05-07 2009-09-30 石家庄永生华清液晶有限公司 Liquid crystal composition
CN103131426A (en) * 2011-11-25 2013-06-05 达兴材料股份有限公司 Liquid crystal compound and liquid crystal medium
CN103058836A (en) * 2012-01-18 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing indan and difluoro methylenedioxy bridge, as well as preparation method and application thereof
CN102924243A (en) * 2012-03-27 2013-02-13 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and applications thereof
CN102994098A (en) * 2012-05-03 2013-03-27 石家庄诚志永华显示材料有限公司 TFT (Thin Film Transistor) liquid crystal composition and preparation method and application thereof
CN103319444A (en) * 2012-06-20 2013-09-25 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing 4-tetrahydropyran structure and preparation method and application thereof
CN103333146A (en) * 2012-06-20 2013-10-02 石家庄诚志永华显示材料有限公司 Liquid crystal compounds containing 2-alkyltetrahydropyrane structure, and preparation method and application thereof
CN103333139A (en) * 2012-06-20 2013-10-02 石家庄诚志永华显示材料有限公司 Liquid crystal compounds containing tetrahydrofuran structure
CN103320144A (en) * 2012-06-20 2013-09-25 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing dihydrobenzofuran and preparation method and application thereof
CN103602337A (en) * 2012-08-17 2014-02-26 石家庄诚志永华显示材料有限公司 Cyclohexane derivatives, preparation method thereof and applications thereof
CN103467253A (en) * 2012-09-24 2013-12-25 石家庄诚志永华显示材料有限公司 Cycloheptane derivative as well as preparation method and application thereof
CN103467251A (en) * 2012-09-24 2013-12-25 石家庄诚志永华显示材料有限公司 Adamantane derivative and preparation method and application thereof
CN102994100A (en) * 2012-10-11 2013-03-27 江苏和成显示科技股份有限公司 Liquid crystal composition and liquid crystal display device containing liquid crystal composition
CN102898413A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Novel liquid crystal compound with dioxa saturated indene ring and composition thereof
CN102911673A (en) * 2012-10-13 2013-02-06 江苏和成显示科技股份有限公司 Liquid crystal composite and electro-optical display device comprising same
CN102899054A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Liquid crystal composition with improved liquid crystal low-temperature smectic phase
CN102899051A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Liquid crystal medium and displayer having same
CN102898272A (en) * 2012-10-13 2013-01-30 江苏和成显示科技股份有限公司 Hexahydroindene-containing novel liquid crystal and composition and use thereof in liquid crystal displayers
CN102888228A (en) * 2012-10-13 2013-01-23 江苏和成显示科技股份有限公司 Liquid crystal composition and display comprising same
CN102964226A (en) * 2012-12-14 2013-03-13 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclobutyl and difluoromethylenedioxy connecting radical as well as preparation method and application thereof
CN103087037A (en) * 2012-12-20 2013-05-08 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing 1, 3-dioxolane and difluoro-methylenedioxy linking group and preparation method and application of liquid crystal compound
CN103058947A (en) * 2012-12-24 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing benzoxazole and difluoromethylenedioxy bridged linkage and preparation method and application thereof
CN103058968A (en) * 2012-12-24 2013-04-24 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing benzoxazole and difluoromethylenedioxy bridged linkage and preparation method and application thereof
CN103146392A (en) * 2013-02-27 2013-06-12 北京八亿时空液晶科技股份有限公司 Liquid crystal composition for liquid crystal display
CN103205261A (en) * 2013-03-06 2013-07-17 石家庄诚志永华显示材料有限公司 Nematic liquid crystal medium composition
CN103205265A (en) * 2013-03-14 2013-07-17 江苏和成显示科技股份有限公司 Liquid crystal composition and liquid crystal display device

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103254905A (en) * 2013-04-25 2013-08-21 石家庄诚志永华显示材料有限公司 Liquid crystal display composition
CN103254905B (en) * 2013-04-25 2015-12-02 石家庄诚志永华显示材料有限公司 Liquid crystal display composition
CN103289708A (en) * 2013-06-09 2013-09-11 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropic liquid crystal composition
CN103289708B (en) * 2013-06-09 2015-04-08 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropic liquid crystal composition
CN103351871A (en) * 2013-07-09 2013-10-16 石家庄诚志永华显示材料有限公司 Liquid crystal medium suitable for TFT liquid crystal displays
CN103351871B (en) * 2013-07-09 2015-09-09 石家庄诚志永华显示材料有限公司 Be applicable to the liquid crystal media of TFT LCD
CN103351880A (en) * 2013-07-10 2013-10-16 石家庄诚志永华显示材料有限公司 Liquid crystal composition containing difluoromethoxy bridge polar monomer compound
CN103351880B (en) * 2013-07-10 2015-04-08 石家庄诚志永华显示材料有限公司 Liquid crystal composition containing difluoromethoxy bridge polar monomer compound
CN104479689A (en) * 2014-12-29 2015-04-01 石家庄诚志永华显示材料有限公司 Liquid crystal composition
CN104560058A (en) * 2015-01-13 2015-04-29 石家庄诚志永华显示材料有限公司 Liquid crystal composition and application thereof in liquid crystal display
CN105441088A (en) * 2015-12-08 2016-03-30 石家庄诚志永华显示材料有限公司 Liquid crystal composition and liquid crystal display element or liquid crystal display containing liquid crystal composition
CN111117658A (en) * 2018-10-30 2020-05-08 江苏和成显示科技有限公司 Liquid crystal composition and display device thereof

Also Published As

Publication number Publication date
CN103409146B (en) 2015-10-28

Similar Documents

Publication Publication Date Title
CN103409146B (en) For the liquid-crystal composition of driven with active matrix liquid-crystal display
KR101687596B1 (en) Nematic liquid crystal composition and liquid crystal display element using same
WO2014117692A1 (en) Polymer stable alignment type liquid crystal composition and use thereof
JP5761479B1 (en) Nematic liquid crystal composition and liquid crystal display device using the same
TWI553105B (en) Liquid crystal composition and use thereof, and liquid crystal display device
TW201444957A (en) Liquid crystal composition and usage thereof and liquid crystal display element
TW201516133A (en) Liquid crystal composition and use thereof, and liquid crystal display element
JP6299580B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
JP6555450B1 (en) Liquid crystal display element
CN105324461A (en) Nematic liquid-crystal composition and liquid-crystal display element obtained using same
JP6660574B2 (en) Liquid crystal display device
CN104334685A (en) Nematic liquid crystal composition and liquid crystal display element using same
CN103361077B (en) Liquid crystal composition and display comprising same
TW201522588A (en) Liquid crystal composition and use thereof, and liquid crystal display element
CN103205263B (en) Liquid crystal composition and liquid crystal display device
CN104342169B (en) A kind of liquid-crystal composition and application thereof that is applicable to in-plane switching mode
TWI630264B (en) Liquid crystal composition and use thereof, and liquid crystal display element
CN109135764B (en) Liquid crystal composition with negative dielectric anisotropy and liquid crystal display device
CN112048314B (en) Liquid crystal composition and display device thereof
CN112048319B (en) Liquid crystal composition and display device thereof
CN103484130B (en) Liquid crystal composition containing butyl and alkyl compounds
CN104371741B (en) Liquid-crystal composition and application thereof
CN114437738B (en) Liquid crystal composition and liquid crystal display device thereof
CN112048320B (en) Liquid crystal composition and display device thereof
CN111117660B (en) Liquid crystal composition and liquid crystal display device thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant